The top 15 highest-paid biopharma executives | Fierce Pharma
Highest-Paid CEOs in Pharma and Biotech: Insider Compensation Analysis
BMS/Celgene Post-Merger Early R&D Strategy: Partnerships Are Still Key, Vessey Says :: Scrip
Bristol-Myers Squibb-Celgene Deal Faces Opposition and Breakup Fee
In Conversation: Bristol-Myers Squibb (NYSE: BMY) CEO say he likes their Bay Area footprint - San Francisco Business Times
Giovanni Caforio, Bristol-Myers Squibb Co: Profile and Biography - Bloomberg Markets
Bristol CEO Giovanni Caforio on new drug launches, acquisitions in 2022
Bristol-Myers Squibb 2021 Proxy Statement
Bristol Myers CEO Giovanni Caforio takes pay cut as 'human capital' metric drags down bonus | Fierce Pharma
Katie Couric, Murdo Gordon, Giovanni Caforio - Murdo Gordon Photos - Zimbio
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO | Fierce Pharma
Giovanni Caforio, Biopharma Chief Executive Officer and Public Policy Advocate, to Speak at Stevens' 149th Commencement | Stevens Institute of Technology
Bristol-Myers Squibb 2021 Proxy Statement
A Big Biotech Bet Hiding in Plain Sight - WSJ
Our Leadership Team - Bristol Myers Squibb
Bristol-Myers Squibb (BMY): Investment Case Getting Better And Better-A Great Time To Buy | Seeking Alpha
Bristol Myers Squibb on Twitter: "Our CEO Giovanni Caforio will be on @BloombergTV today at 3:30 p.m. ET to discuss our progress in scientific innovation for patients with @CarolineHydeTV, @romainebostick & @RiggsReport.
10 Things You Didn't Know about Bristol Myers Squibb CEO Giovanni Caforio
Giovanni Caforio On Becoming the Chairman of PhRMA - Bristol Myers Squibb
Bristol Myers Squibb 2023 Proxy Statement
Giovanni Caforio Remarks on U.S. Drug Pricing - Bristol Myers Squibb
Bristol-Myers Squibb Company
Julia Ding - Devens, Massachusetts, United States | Professional Profile | LinkedIn
Dr. Giovanni Caforio, M.D. | USPTO
Bristol Myers Squibb - Wikipedia
